back to US directory
us clinical guidance

Functional constipation in children and adolescents

Current AGA鈥揘ASPGHAN assessment and stepwise care emphasizing clinical diagnosis, alarm features, disimpaction, maintenance, behavioral support and escalation.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Children and adolescents with suspected functional constipation, including neurodivergent children who may need adapted communication and toileting support. The April 2026 AGA鈥揘ASPGHAN care pathway spans pediatric ages but stresses that organic disease is more likely in infants and very young children. Acute surgical abdomen, toxic megacolon, bowel obstruction and known complex neurologic or anatomic disease are outside routine functional management.
sources for this section:AGA鈥揘ASPGHAN constipation 2026

The Bottom Line

  • Diagnose typical functional constipation from symptom pattern, stool withholding, painful or hard stools, fecal incontinence and examination; routine abdominal radiography, broad laboratory screening or invasive testing is unnecessary when history and examination are characteristic and alarm features are absent.
  • Look actively for fecal impaction and clear it before expecting maintenance treatment to work. Select an age- and weight-appropriate disimpaction plan from the current local formulary and provide a clear rescue plan if the initial route fails.
  • After disimpaction, use regular maintenance laxative therapy plus scheduled unhurried toilet sitting, positive reinforcement and practical school or caregiver support; diet and fluids support health but should not replace adequate pharmacologic treatment of established constipation.
  • Titrate treatment to comfortable frequent stools and resolution of withholding and overflow, and continue long enough for rectal function and toileting behavior to recover rather than stopping immediately after the first normal stool.
  • For persistent symptoms, verify diagnosis, adherence, dose, administration, toilet access and psychosocial barriers before labeling disease refractory; then escalate through gastroenterology and, when appropriate, motility, behavioral, pelvic-floor or surgical expertise.
sources for this section:AGA鈥揘ASPGHAN constipation 2026

Practical clinical workflow

1
Record onset relative to birth and toilet training, meconium history, stool frequency and caliber, pain, bleeding, withholding, soiling, urinary symptoms, diet, medicines, development, growth and family history of endocrine, celiac, neurologic or Hirschsprung disease.
2
Assess growth, abdomen, perianal region and lumbosacral and lower-limb neurologic findings when clinically indicated; use a rectal examination only when it will answer a specific question and can be performed safely and respectfully.
3
Identify impaction and institute the current local oral or rectal disimpaction regimen with family agreement, expected effects and hydration advice, then transition directly into maintenance rather than leaving a treatment gap.
4
Create a written home and school plan for regular medicine, toilet sitting after meals, foot support, symptom tracking and what to do after missed doses, recurrent withholding or breakthrough soiling.
5
Review response and adverse effects at defined intervals, taper only after sustained symptom control and successful toileting, and establish transition ownership for adolescents with chronic or complex constipation.
sources for this section:AGA鈥揘ASPGHAN constipation 2026

Safety boundaries and escalation

  • Delayed meconium, onset in the first weeks of life, bilious vomiting, marked distension, faltering growth, fever, abnormal anus, sacral or lower-limb neurologic findings or explosive emptying after examination requires evaluation for organic disease.
  • Severe abdominal pain with peritoneal signs, persistent vomiting, systemic toxicity or suspected obstruction is not an outpatient clean-out scenario and requires urgent surgical assessment.
  • Do not blame the child for soiling or withholding; pain, sensory needs, trauma, school toilet access and family stress can sustain symptoms and require supportive, nonpunitive care.
  • Before calling constipation refractory or considering surgery, confirm adequate medical and behavioral treatment and use a multidisciplinary specialist assessment as required by the AGA鈥揘ASPGHAN pathway.
sources for this section:AGA鈥揘ASPGHAN constipation 2026

Localization

The April 2026 AGA鈥揘ASPGHAN pathway is the current US society source. clinicians must use current FDA labeling, pediatric pharmacy guidance and local formulary dosing. Insurance coverage, access to motility testing and school accommodation processes vary by state and health system and should be addressed explicitly in the care plan.
sources for this section:AGA鈥揘ASPGHAN constipation 2026

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American Gastroenterological Association and North American Society for Pediatric Gastroenterology, Hepatology and NutritionAGA-NASPGHAN Pediatric Functional Constipation Clinical Care PathwayDOI 10.1016/j.cgh.2026.03.003; PMID 41935596 路 published 2026-04-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.